News

Oscar Health cut to underweight at Wells Fargo on pricing concerns
Oscar Health (NYSE:OSCR) downgraded by Wells Fargo amid rising medical cost concerns and 2025 pricing challenges. Read more here.
ZME Science on MSN19h
Ozempic Is Changing More Than Waistlines as Scientists Wise Up to Concerning Side Effects
In recent years, the popularity of weight-loss drugs like Ozempic and Wegovy has soared so dramatically that they’ve inspired new vocabulary, spurred global shortages, and prompted moral debates.